Penn Medicine Abramson Cancer Center
Plenary Sessions
Penn Medicine Cellicon Valley '23: The Future of Cell and Gene Therapies
Gene Therapy: A Case Study for Disruptive Technology
FEATURING
James Wilson
- 80 views
- August 14, 2023
Penn Medicine Cellicon Valley '23: The Future of Cell and Gene Therapies
Hemophilia A & B: Model Monogenic Disorders for Gene Therapy
FEATURING
Lindsey George
- 51 views
- August 11, 2023
Penn Medicine Cellicon Valley '23: The Future of Cell and Gene Therapies
Curative Potential of CAR T-Cell Therapy for ALL
FEATURING
Stephan Grupp
- 212 views
- August 11, 2023
Penn Medicine Cellicon Valley '23: The Future of Cell and Gene Therapies
Long-Term Data in Lymphoma: Can CAR T-Cells Cure Patients?
FEATURING
Frederick L. Locke
- 105 views
- August 11, 2023
Penn Medicine Cellicon Valley '23: The Future of Cell and Gene Therapies
Updates on CAR T-Cell Therapy for T-Cell ALL
FEATURING
David Teachey
- 73 views
- August 11, 2023
Penn Medicine Cellicon Valley '23: The Future of Cell and Gene Therapies
Global Expansion of CAR T-Cell Therapy: India
FEATURING
Arun Anand
- 5 views
- August 10, 2023
Penn Medicine Cellicon Valley '23: The Future of Cell and Gene Therapies
Global Expansion of CAR T-Cell Therapy: Middle East
FEATURING
Shahrukh Hashmi
- 5 views
- August 10, 2023
Penn Medicine Cellicon Valley '23: The Future of Cell and Gene Therapies
Programming Cellular Machines to Sense and Treat Disease
FEATURING
Wendell Lim
- 32 views
- August 10, 2023
Penn Medicine Cellicon Valley '23: The Future of Cell and Gene Therapies
Nucleoside-Modified mRNA-LNP Therapies
FEATURING
Drew Weissman
- 18 views
- August 10, 2023
- 2
Penn Medicine Cellicon Valley '23: The Future of Cell and Gene Therapies
The Improbable History of CAR T-Cells
FEATURING
Carl June
- 565 views
- August 10, 2023
- 3